What is the appropriate workup for hematuria in a 75-year-old man with a smoking history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Hematuria in a 75-Year-Old Man with Smoking History

This 75-year-old male smoker with hematuria requires a complete urologic evaluation including CT urography (CTU) and cystoscopy, as he has multiple high-risk features for urinary tract malignancy with up to a 30-40% risk of cancer if gross hematuria is present. 1

Risk Stratification

Your patient falls into the high-risk category based on:

  • Age >60 years (male)
  • Smoking history (major risk factor for urothelial malignancy)
  • Male gender

These factors place him at significantly elevated risk for bladder cancer and upper tract urothelial carcinoma, with malignancy rates ranging from 1.3% to 6.3% for microhematuria and up to 30-40% for gross hematuria. 1, 2

Initial Clinical Assessment

Perform focused evaluation looking specifically for:

  • Smoking quantification: Document pack-years and current tobacco use 2
  • Type of hematuria: Gross versus microscopic (visible blood dramatically increases malignancy risk) 1
  • Irritative voiding symptoms: Urgency, frequency, dysuria (suggests carcinoma in situ) 1, 3
  • Occupational exposures: Chemical, dye, benzene, aromatic amine exposure 3
  • Prior pelvic radiation or cyclophosphamide use 3
  • Serum creatinine: Assess renal function before contrast imaging 3
  • Blood pressure: Screen for renal parenchymal disease 3
  • Urinalysis with microscopy: Confirm hematuria, look for dysmorphic RBCs, proteinuria, or cellular casts suggesting glomerular disease 1, 3

Critical pitfall: Do NOT assume anticoagulation or antiplatelet therapy explains the hematuria—these patients still require full urologic evaluation. 1

Mandatory Imaging: CT Urography

Multi-phasic CT urography is the imaging procedure of choice for this patient. 3, 1

CTU protocol must include:

  • Unenhanced phase: Detects stones and baseline renal masses
  • Nephrographic phase: Evaluates renal parenchyma for masses
  • Excretory phase (≥5 minutes post-contrast): Visualizes urothelium of upper tracts, ureters, and bladder
  • Thin-slice acquisition with multiplanar reconstructions 1

This comprehensive imaging evaluates the entire urinary tract from kidneys to bladder for stones, masses, and urothelial lesions. Alternative imaging (MR urography, ultrasound) is inferior and should only be used if CTU is contraindicated due to renal insufficiency or contrast allergy. 3, 1

Mandatory Cystoscopy

Cystoscopy is non-negotiable for this patient regardless of imaging findings. 3, 4

Rationale:

  • Age >35 years is an absolute indication for cystoscopy 3
  • Smoking history mandates cystoscopy at any age 3, 1
  • Most urologic malignancies in hematuria patients are bladder cancers, which are optimally detected by cystoscopy, not imaging 2
  • Even if CTU shows a "benign" upper tract source (like stones), bladder cancer must still be excluded 4

Flexible cystoscopy under local anesthesia is preferred—it causes less pain, has equivalent diagnostic accuracy to rigid cystoscopy, and can be performed in the office setting. 4

Additional Testing Considerations

Urine cytology is NOT routinely recommended in initial evaluation 5, 6. However, consider obtaining it if:

  • Persistent hematuria after negative workup with irritative voiding symptoms
  • High suspicion for carcinoma in situ 5

Nephrologic evaluation is indicated ONLY if you find:

  • Dysmorphic RBCs
  • Proteinuria
  • Cellular casts
  • Elevated creatinine
  • Hypertension with persistent hematuria 1, 3, 4

These findings suggest glomerular disease, but nephrologic workup should occur concurrently with—not instead of—urologic evaluation. 1, 3

Critical Clinical Pearls

Do not delay evaluation if urinary tract infection is suspected—treat the infection, but if hematuria persists after appropriate antibiotic therapy, proceed with full urologic workup. 1

Timing matters: Delays in bladder cancer diagnosis increase cancer-specific mortality by 34% and all-cause mortality by 15%. 2

If initial workup is negative: This patient still requires surveillance given his high-risk profile. Follow-up should include repeat urinalysis at 6,12,24, and 36 months, with immediate re-evaluation if gross hematuria develops, degree of microhematuria significantly increases, or new urologic symptoms appear. 4, 5, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.